NIMISH GERA
Company: Mythic Therapeutics
Job title: Vice President, Biologics
Seminars:
Chairs Opening Remarks 9:25 am
day: Conference Day Two
Panel Discussion: Overtaking CAR-T & ADCs in Relapsed/Refractory Multiple Myeloma Treatments: How Do Bispecific Therapies Fare in the Clinic? 10:00 am
Setting the scene: bispecific antibodies as next class of treatments for multiple myeloma to emerge in the clinic Comparing the safety and efficacy profiles of these two treatments for a heavily pre-treated patient population Debating combination of the two therapies: which should be used first and does the usage of one prevent the future utility…Read more
day: Conference Day Two